# Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

> **NCT06202274** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Candela Corporation** · enrollment: 500 (estimated)

## Conditions studied

- Hair Reduction
- Tattoo Removal
- Wrinkle
- Acne
- Scars
- Benign Cutaneous Vascular Lesions
- Skin Conditions

## Interventions

- **DEVICE:** Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE

## Key facts

- **NCT ID:** NCT06202274
- **Lead sponsor:** Candela Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-04
- **Primary completion:** 2028-10-04
- **Final completion:** 2029-10-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202274, "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06202274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*